Skip to main content

Table 2 Treatment outcome after trimodal therapy

From: Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis

Univariate analysis MST (months) 5-year survival (%) P
Resection status    
  R0 33 37.6 0.54
  R1 31 43.5
Histology    
  Squamous cell 43 42.5 0.20
  Adenocarcinoma 21 36.0
Chemotherapy    
  Induction 36 38.7 0.87
  Adjuvant 32 38.7
Type of surgery    
  Lobectomy 43 51.9 0.054
  Bi-lobe/Pneumonectomy 22 19.5  
  1. Univariate analysis.